Hematopoietic
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder (NCT06261060) | M.D. Anderson Cancer Center | 2024-06-20 |
Track Hematopoietic automatically
Every clearance here is in the API, with alerts when new ones post.